Corrigendum to "Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms".

[This corrects the article DOI: 10.1155/2020/8379526.].

In the article titled “Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms” [1], the authors mistakenly generated the line graph of Figure 1(c) using the data from Figure 1(b). The corrected figure is provided as follows.

Figure 1

Cytotoxicity of NAP on human oral keratinocytes, human gingival epithelial cells, and macrophages. (a) Chemical structure of napabucasin; (b) viability of HOK treated with NAP and CHX: IC50NAP > 62.5 μg/mL and IC50CHX = 31.25 ~ 62.5 μg/mL; (c) viability of HGE treated with NAP and CHX: IC50NAP > 62.5 μg/mL and IC50CHX > 62.5 μg/mL; (d) viability of RAW264.7 treated with NAP and CHX: IC50NAP > 62.5 μg/mL and IC50CHX = 31.25 ~ 62.5 μg/mL. HOK: human oral keratinocytes; HGE: human gingival epithelial cells; RAW264.7: macrophages RAW264.7.